Andrew Schiermeier
Algemeen Directeur bij AvenCell Therapeutics, Inc.
Actieve functies van Andrew Schiermeier
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Kynan Pharmaceuticals | Directeur/Bestuurslid | - | - |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Directeur/Bestuurslid | 01-08-2021 | - |
| Algemeen Directeur | 01-08-2021 | - | |
Regel Therapeutics Inc.
 Regel Therapeutics Inc. BiotechnologyHealth Technology Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020. | Directeur/Bestuurslid | - | - |
Loopbaan van Andrew Schiermeier
Eerdere bekende functies van Andrew Schiermeier
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Operationeel Directeur | - | 21-06-2021 |
| Corporate Officer/Principal | 01-04-2018 | - | |
| MERCK KGAA | Corporate Officer/Principal | 01-05-2013 | 01-01-2016 |
| AURA BIOSCIENCES, INC. | Operationeel Directeur | 01-01-2011 | 01-05-2013 |
Opleiding van Andrew Schiermeier
| Harvard University | Doctorate Degree |
| Stanford University | Graduate Degree |
| College des Ingenieurs | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Duitsland | 2 |
| Frankrijk | 2 |
Operationeel
| Director/Board Member | 3 |
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK KGAA | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Kynan Pharmaceuticals | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
Regel Therapeutics Inc.
Regel Therapeutics Inc. BiotechnologyHealth Technology Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020. | Health Technology |
- Beurs
- Insiders
- Andrew Schiermeier
- Ervaring
